NCT01162135 2025-05-04Digoxin for Recurrent Prostate CancerThomas Jefferson UniversityPhase 2 Completed16 enrolled 7 charts
NCT04094519 2024-11-20A Study to Evaluate the Effect of Multiple Doses of Enzalutamide on the Pharmacokinetics of Substrates of P-glycoprotein (Digoxin) and Breast Cancer Resistant Protein (Rosuvastatin) in Male Subjects With Prostate CancerAstellas Pharma IncPhase 1 Completed24 enrolled